Aspira Pathlab IDC Recommends Open Offer for 26% Stake at ₹55/Share

Aspira Pathlab & Diagnostics Ltd's Independent Director Committee (IDC) has submitted its recommendation, deeming the open offer fair and reasonable. The offer, made by Mr. Arvind Karsandas Bhanushali and other acquirers along with a PAC, aims to acquire 26,76,180 fully paid-up equity shares, representing 26% of the company's equity share capital. The acquisition price is ₹55 per equity share, payable in cash. The IDC members, who are independent directors with no equity holdings or other relationships with the company or acquirers, based their recommendation on a review of the public announcement and detailed public statement, ensuring compliance with SEBI (SAST) Regulations, 2011.